Bangladesh is a rustic of rising economy. The causes of its rising is high rate of industrialization and investment in different sectors. The pharmaceutical sector that is the second largest export earning source of the country after Ready Made Garments contributes almost 1% of the GDP and is currently the third largest tax paying sector in the country. Square Pharmaceutical Limited (SPL) the biggest name in the pharmaceutical sector of Bangladesh has a market share of 19.3% and the total exporting amount become BDT 1,137.99 millions in FY 2016-2017 that is 34.46% more than the previous year. This paper is almost done using the secondary data though a slight primary data is used where customer’s choice is ...
This article was published in BMC Medical Ethics [© 2015 BioMed Central Ltd.] and the definite versi...
The pharmaceutical industry is a sunrise industry in China’s high-tech industries. This article stud...
Developing countries have been motivated by concern that higher levels of intellectual property prot...
Bangladesh is a rustic of rising economy. The causes of its rising is high rate of industrialization...
The purpose of this paper is to focus on corporate social reporting by the pharmaceutical companies ...
Bangladesh has made impressive economic and social progress in the past decade, despite frequent nat...
With the rapid growth of trade, commerce and industries, the numbers of publicly traded companies ar...
This policy brief - "Growth of Bangladesh’s Pharma Industry: Some Implications" - is part of an ongo...
This article highlights the unethical practices of pharmaceutical industries in Bangladesh in their ...
2.1 Introduction This chapter discusses the legislative framework for patents and the pharmaceutical...
Indian pharmaceutical history began from Gupta period which was existed from approximately 320 to 55...
In mid-1991, the liberalization process that has been taken by the government of India, made a path ...
2.1 Introduction This chapter discusses the legislative framework for patents and the pharmaceutical...
Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the pr...
Includes bibliographical references (page 9).Background: The pharmaceutical market in Bangladesh is ...
This article was published in BMC Medical Ethics [© 2015 BioMed Central Ltd.] and the definite versi...
The pharmaceutical industry is a sunrise industry in China’s high-tech industries. This article stud...
Developing countries have been motivated by concern that higher levels of intellectual property prot...
Bangladesh is a rustic of rising economy. The causes of its rising is high rate of industrialization...
The purpose of this paper is to focus on corporate social reporting by the pharmaceutical companies ...
Bangladesh has made impressive economic and social progress in the past decade, despite frequent nat...
With the rapid growth of trade, commerce and industries, the numbers of publicly traded companies ar...
This policy brief - "Growth of Bangladesh’s Pharma Industry: Some Implications" - is part of an ongo...
This article highlights the unethical practices of pharmaceutical industries in Bangladesh in their ...
2.1 Introduction This chapter discusses the legislative framework for patents and the pharmaceutical...
Indian pharmaceutical history began from Gupta period which was existed from approximately 320 to 55...
In mid-1991, the liberalization process that has been taken by the government of India, made a path ...
2.1 Introduction This chapter discusses the legislative framework for patents and the pharmaceutical...
Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the pr...
Includes bibliographical references (page 9).Background: The pharmaceutical market in Bangladesh is ...
This article was published in BMC Medical Ethics [© 2015 BioMed Central Ltd.] and the definite versi...
The pharmaceutical industry is a sunrise industry in China’s high-tech industries. This article stud...
Developing countries have been motivated by concern that higher levels of intellectual property prot...